Supporting prostate cancer research

A randomised controlled trial of iCanADAPT, an internet Cognitive Behavioural Therapy (iCBT) program for the treatment of depression and anxiety in early-stage cancer patients and cancer survivors.

Prof Gavin Andrews and Dr Michael Murphy, University of New South Wales.

This trial tested an internet-based program (iCanADAPT Early) for the treatment of depression and anxiety in early stage cancer patients and cancer survivors. This program uses a well-developed psychological therapy called cognitive behavioural therapy.

iCanADAPT is a free online course consisting of eight lessons to be completed over 16 weeks. The course is based on general cognitive behavioural therapy (CBT) skills that have been tailored to target worries and low mood associated with cancer.

Participants completed a set of questionnaires including the Hospital Anxiety and Depression Scale (HADS). Those men suitable for the iCanADAPT Research Trial completed a short, telephone interview, to further assess for criteria of depression or anxiety. Once the application process is complete, those who are suitable for our trial were randomly allocated to either Group 1, who get access to the iCanADAPT program up front, or to Group 2, who get access to the program after a waiting period of 16 weeks. Participants in both groups could access their standard treatment and support during the trial.

This study is no longer recruiting participants.

Join us today!

Pathfinder is a unique prostate cancer research register that enables prostate cancer survivors to participate in research for a brighter future with their loved ones.

It will enable researchers to save valuable time and money recruiting participants for their projects, so that they can spend more time delivering health benefits to those in need. Click the button to the right to register!